LN9391548
98%
| Pack Size | Price | Stock | Quantity |
| 25mg | RMB586.40 | In Stock |
|
| 100mg | RMB1172.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 746.4±70.0 °C(Predicted) |
| Density | 1.294±0.06 g/cm3(Predicted) |
| pka | 5.24±0.10(Predicted) |
| InChIKey | QVJKVBFRYVEWGO-UHFFFAOYSA-N |
| SMILES | N1(C(OC(C)(C)C)=O)CCN(C2=CC=C(NC3=NC=C4C(C)=C(C(C)=O)C(=O)N(C5CCCC5)C4=N3)N=C2)CC1 |
Description and Uses
N-Boc Palbociclib is a protected Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.





![6-bromo-2-chloro-8-cyclopentyl-5-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one](https://img.chemicalbook.com/CAS/GIF/1016636-76-2.gif)
